Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
10.21%
↑ 376% vs avg
Percentile
P82
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
2.14%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 10.21% |
| Q3 2025 | 32.10% |
| Q2 2025 | 53.49% |
| Q1 2025 | 32.90% |
| Q4 2024 | 66.39% |
| Q3 2024 | 328.67% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -12.00% |
| Q4 2018 | -4.17% |
| Q3 2018 | 0.00% |
| Q2 2018 | -4.35% |
| Q1 2018 | 61.67% |
| Q4 2017 | -566.67% |
| Q3 2017 | -12.50% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |